PortfoliosLab logo

Aptose Biosciences Inc. (APS.TO)

Equity · Currency in CAD · Last updated Dec 1, 2022

Company Info

ISINCA03835T2002
CUSIP03835T200
SectorHealthcare
IndustryBiotechnology

APS.TOShare Price Chart


Loading data...

APS.TOPerformance

The chart shows the growth of CA$10,000 invested in Aptose Biosciences Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$333 for a total return of roughly -96.67%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovember
-25.67%
-0.71%
APS.TO (Aptose Biosciences Inc.)
Benchmark (^GSPC)

APS.TOCompare to other instruments

Search for stocks, ETFs, and funds to compare with APS.TO

APS.TOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M34.33%4.59%
6M-30.23%-1.27%
YTD-50.00%-16.50%
1Y-67.86%-15.37%
5Y-19.40%5.96%
10Y-15.76%9.59%

APS.TOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-8.33%-8.48%12.58%-11.18%-14.57%-26.36%3.16%7.14%-21.90%-23.17%42.86%
2021-5.55%-3.98%48.52%-8.37%-6.67%-36.34%-17.80%11.28%-26.67%-6.55%8.56%-35.48%
202023.67%17.71%-23.36%16.83%5.32%-15.46%-20.98%8.31%8.90%-24.65%44.74%-35.52%
20190.00%-11.15%16.45%-4.09%5.04%25.83%-2.35%-3.90%-13.75%-1.99%33.83%103.04%
201833.09%-2.70%12.78%2.96%10.29%12.36%-23.36%-4.03%-12.07%-14.63%5.94%-14.19%
2017-30.94%20.00%-10.00%-11.85%16.81%16.55%10.49%-1.68%5.11%10.27%28.92%5.70%
201614.44%-7.77%0.53%-19.11%14.56%-9.60%3.13%-12.73%2.78%-54.05%-8.82%45.97%
2015-8.30%-1.59%10.32%0.88%2.90%-9.86%-7.19%18.86%-17.85%29.48%-46.87%-9.77%
20143.51%32.20%-24.36%-3.39%-21.05%8.89%-3.06%9.47%3.85%28.09%0.60%-17.72%
20136.45%-19.70%7.55%-29.82%10.00%-4.55%-4.76%-10.00%38.89%116.00%-1.85%7.55%
201210.26%-6.98%40.00%-7.14%50.00%20.51%2.13%-8.33%-5.68%-22.89%25.00%-22.50%
2011-9.17%-1.01%-14.29%-4.76%-15.00%-34.56%-5.62%-28.57%11.67%-25.37%-18.00%-4.88%
2010-20.00%75.00%-28.57%13.33%-16.86%-3.30%-14.63%-27.43%-14.96%-7.41%15.00%-5.22%

APS.TOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aptose Biosciences Inc. Sharpe ratio is -0.82. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20JulyAugustSeptemberOctoberNovember
-0.82
-0.59
APS.TO (Aptose Biosciences Inc.)
Benchmark (^GSPC)

APS.TODividend History


Aptose Biosciences Inc. doesn't pay dividends

APS.TODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-97.83%
-16.75%
APS.TO (Aptose Biosciences Inc.)
Benchmark (^GSPC)

APS.TOWorst Drawdowns

The table below shows the maximum drawdowns of the Aptose Biosciences Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aptose Biosciences Inc. is 98.48%, recorded on Oct 25, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.48%Feb 25, 20103026Oct 25, 2022
-20%Jan 5, 201035Feb 23, 20101Feb 24, 201036

APS.TOVolatility Chart

Current Aptose Biosciences Inc. volatility is 44.84%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%JulyAugustSeptemberOctoberNovember
44.84%
20.28%
APS.TO (Aptose Biosciences Inc.)
Benchmark (^GSPC)